William Wirshing
Psychiatry · Los Angeles, CANPI 1265621601
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $179,792 of the $204,857 with a category attached, or 87.8%. ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) accounts for 63.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $51,391 and has fallen 99.3% since, to $340 in 2025. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 214 payments — averaging $957.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$129K
- Otsuka America Pharmaceutical, Inc.$26K
- Otsuka Pharmaceutical Co., Ltd.$17K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$12K
- Alkermes, Inc.$12K
- Sunovion Pharmaceuticals Inc.$7K
- plus $3K from 8 others
What the payments were for
- Consulting fees$4,8602%
- Speaking & faculty fees$179,79288%
- Travel & lodging$14,3367%
- Food & beverage$5,7343%
- Education$1350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 111 | $129,260 |
| Otsuka America Pharmaceutical, Inc. | 39 | $25,848 |
| Otsuka Pharmaceutical Co., Ltd. | 6 | $16,715 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 11 | $11,726 |
| Alkermes, Inc. | 8 | $11,550 |
| Sunovion Pharmaceuticals Inc. | 14 | $6,820 |
| Johnson & Johnson | 7 | $2,128 |
| Neurocrine Biosciences, Inc. | 6 | $532 |
| E.r. Squibb & Sons, L.L.C. | 4 | $114 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
| Indivior Inc. | 2 | $45 |
| AbbVie | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Bausch Health US, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$127,512
- ARISTADA$46,039
- ABILIFY MAINTENA$38,763
- ARISTADA INITIO$11,510
- LATUDA$6,629
- SPRAVATO$2,020
- REXULTI$933
- INGREZZA$450
How this compares
$204,857 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Los Angeles
- Jakub JurosLos Angeles$394K
- Derek OttLos Angeles$329K
- Gil HoftmanLos Angeles$200K
- Lon SchneiderLos Angeles$156K
- Stephen MarderLos Angeles$103K
- John BrooksLos Angeles$80K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.